![A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma]()
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanomaMehnert, Janice M.; Silk, Ann W.; Wen, Yu; Lee, J. H.; Dudek, Liesel; Jeong, Byeong-Seon; Li, Jiadong; Schenkel, Jason M.; Sadimin, Evita; Kane, Michael; Lin, Hongxia; Shih, Weichung J.; Zloza, Andrew; Chen, Suzie; Goydos, James. S. · Pigment Cell & Melanoma Research · 2018